BIOSPECIFICS TECHNOLOGIES CORP Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 4 rows in 2000. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2000-12-27: Reporting owner Wegman Thomas; Form 5/A; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2000-12-27: Reporting owner Wegman Thomas; Form 5; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2000-06-05: Reporting owner Morgan Henry; Form 5; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2000-06-05: Reporting owner Gitman Paul; Form 5; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2000-12-27 | Wegman Thomas Director, Officer (President) | 5/A | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $1.00 exercise price | 2006-12-07 | |
| 2000-12-27 | Wegman Thomas Director, Officer (President) | 5 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $1.00 exercise price | 2006-10-10 | |
| 2000-06-05 | Morgan Henry Director | 5 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $2.56 exercise price | 2006-10-10 | |
| 2000-06-05 | Gitman Paul Director | 5 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $2.56 exercise price | 2006-10-10 |